Revolution Medicines (RVMD) earnings, Aug 5, 2026: EPS −134%, stock +2.0%
In brief
Revolution Medicines reported on Aug 5, 2026. Earnings per share changed −134% year over year, 49.8% below the estimate; revenue 0%. The stock opened with a +0.3% gap and closed the day +2.0% (Aug 5, 2026). The stock is now 20.8% below its 52-week high, +199.4% over 12 months. Next report: Mar 1, 2027.
EPS vs estimate−49.8%
EPS, YoY−134%
Revenue, YoY0%
Gap · day+0.3% · +2.0%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 5, 2026 | +0.3% | +2.0% |
Next-quarter estimates, ratings and the RVMD chart are in the terminal.
Open the terminalFAQ
When is Revolution Medicines's next earnings report?
Mar 1, 2027. The date comes from daily data and is corrected if the company moves it.
How did Revolution Medicines stock react to the report?
Opening gap +0.3%, day's result +2.0%.
Did Revolution Medicines's earnings grow?
Earnings per share fell 134% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.